Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-12-07 Quinn Anthony G. President & CEO Option exercise · Director Stock Option (right to buy) −18,584 144,950
2018-09-27 Schuchart Aaron Chief Business Officer Sale −100 $9.55 $955 8,400
2018-09-27 Schuchart Aaron Chief Business Officer Sale −5,900 $9.50 $56K 2,500
2018-08-17 Schuchart Aaron Chief Business Officer Option exercise +8,500 $3.50 $30K 8,500
2018-08-17 Schuchart Aaron Chief Business Officer Option exercise · Employee Stock Option (right to buy) −8,500 91,500
2018-08-15 Quinn Anthony G. President & CEO Purchase +994 $9.13 $9K 95,787
2018-08-13 GEORGIOU GEORGE Director Option exercise +17,333 $7.28 $126K 155,861
2018-08-13 GEORGIOU GEORGE Director Option exercise +20,000 $4.73 $95K 175,861
2018-08-13 GEORGIOU GEORGE Director Option exercise · Director Stock Option (right to buy) −17,333 6,667
2018-08-13 GEORGIOU GEORGE Director Option exercise · Director Stock Option (right to buy) −20,000 10,000
2018-07-18 Quinn Anthony G. President & CEO Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2018-07-18 Quinn Anthony G. President & CEO Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2018-07-18 Quinn Anthony G. President & CEO Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2018-07-18 Quinn Anthony G. President & CEO Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2018-07-13 LAWLIS V BRYAN Director Grant or award · Director Stock Option (right to buy) +36,800 36,800
2018-07-12 Quinn Anthony G. Interim CEO Option exercise +24,000 $7.04 $169K 77,927
2018-07-12 Quinn Anthony G. Interim CEO Option exercise +14,866 $6.31 $94K 92,793
2018-07-12 Quinn Anthony G. Interim CEO Option exercise · Director Stock Option (right to buy) −24,000 0
2018-07-12 Quinn Anthony G. Interim CEO Option exercise · Director Stock Option (right to buy) −14,866 163,534
2018-07-11 Quinn Anthony G. Interim CEO Option exercise +3,307 $5.46 $18K 53,927

Page 16 of 19 · 372 trades